Neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities: genes and variants
Explore variant evidence for Neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities across 1 analyzed protein (GNAI1). Linked ClinVar records include 8 pathogenic or likely pathogenic variants, 8 variants of uncertain significance and 2 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-15. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities
GNAI1: Guanine nucleotide-binding protein G(i) subunit alpha-1
It couples inhibitory G-protein-coupled receptors to downstream effectors, including suppression of adenylyl cyclase and modulation of ion channels. Pathogenic variants can disturb neuronal signaling and have been associated with developmental movement disorders and neurodevelopmental phenotypes.
8 ClinVar pathogenic / likely pathogenic and 10 uncertain variants in GNAI1 have source records linked to Neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities. Association strength is not clinical gene validity.
Where Neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities variants cluster
- GNAI1 G1 motif (positions 35–48): 4 of 8 ClinVar pathogenic / likely pathogenic variants, 12.6× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| GNAI1 T48K | 48 | G-alpha | Pathogenic / likely pathogenic (★★) |
| GNAI1 G45D | 45 | G-alpha | Pathogenic / likely pathogenic (★★) |
| GNAI1 D272N | 272 | G-alpha | Pathogenic / likely pathogenic (★★) |
| GNAI1 D173V | 173 | G-alpha | Pathogenic / likely pathogenic (★★) |
| GNAI1 T48I | 48 | G-alpha | Pathogenic / likely pathogenic (★) |
| GNAI1 G40C | 40 | G-alpha | Pathogenic / likely pathogenic (★) |
| GNAI1 Q204R | 204 | G-alpha | Pathogenic / likely pathogenic (★) |
| GNAI1 D272G | 272 | G-alpha | Pathogenic / likely pathogenic |
Uncertain variants prioritized for review in Neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| GNAI1 T48A | 48 | G-alpha | Uncertain (★) | +6: 3 other pathogenic changes within 3 positions; T48I at the same position is pathogenic; REVEL 0.952 |
Frequently asked questions
Which genes have records linked to Neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities?
This view contains 1 analyzed proteins: GNAI1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 8 pathogenic or likely pathogenic variants, 8 variants of uncertain significance and 2 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 1 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 26 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center